NCT00373061View on ClinicalTrials.gov

An Observational Study of the Use and Safety of Xolair® During Pregnancy

CompletedOBSERVATIONAL

Enrollment

309

Participants

Timeline

Start Date

October 20, 2006

Primary Completion Date

December 11, 2017

Study Completion Date

January 5, 2018

Conditions

Asthma

Interventions

DRUG

Xolair®

This being an observational study, the study protocol does not specify any dose regimen.

Trial Locations (1)

27560-7200

Ppd Development, Llc, Morrisville

Sponsors

Lead Sponsor

Genentech, Inc.

Collaborators (1)

All Listed Sponsors

collaborator

Novartis

INDUSTRY

lead

Genentech, Inc.

INDUSTRY